1Kupker W, Felberbaum RE, Krapp M, et al. Use of GnRH antagonists in the treatment of endometriosis. Reprod Biomed Online, 2002,5(1):12.
2Sidell N, Han SW, Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci, 2002, 955:159.
3Kudoh M, Susaki Y, Ideyama Y, et al. Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulinlike growth factor- Ⅰ gene expression in rats with experimental endometriosis. J Steroid Biochem Mol Biol, 1997,63(1～ 3):75.
4Dogan E, Saygili U, Posaci C, et al. Regression of endometrial explants in rats treated with the cyclooxygenase- 2 inhibitor rofecoxib. Fertil Steril,2004,82(Suppl 3): 1115.
5Abu JI, Konje JC. Leukotrienes in gynaecology: the hypothetical value of anti- leukotriene therapy in dysmenorrhoea and endometriosis. Hum Reprod Update, 2000,6(2):200.
6Ihara T, Uchiide I, Sugamata M. Light and electron microscopic evaluation of antileukotriene therapy for experimental rat endometriosis. Fertil Steril, 2004,81(Suppl 1) :819.
7Xiao YH, Chen DP, Yan JH, et al. Mechanism of action of Tripterygium Wilfordii polyglycoside on experimental endometriosis. Eur J Gynaecol Oncol,2002,23(1) :63.
8Nishida M, Nasu K, Ueda T, et al. Endometriotic cells are resistant to interferon - gamma- induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod, 2005,11(1) :29.
9Mesogitis S, Antsaklis A, Daskalakis G, et al. Combined ultrasonographically guided drainage and methotrexate administration for treatment of endometriotic cysts. Lancet, 2000, 355(9210) :1160.
